Jutte Van Der Werff Ten Bosch

https://orcid.org/0000-0002-2441-9880

Laarbeeklaan 101
1090 Brussels
Belgium
Laarbeeklaan 101
1090 Jette
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise

Clinical sciences, growth and development, pediatrics

Fingerprint

Dive into the research topics where Jutte Van Der Werff Ten Bosch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

4 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Active
2 Finished

FWOAL878: Multi-center randomized controlled trial to test the effectiveness of family-centered advance care planning in adolescents with cancer and their parents (pACP)
Cohen, J., Van Der Werff Ten Bosch, J., Deliens, L. & Laureys, G.
1/01/18 → 31/12/21
Project: Fundamental
FWOAL891: Fertility preservation in boys treated for cancer: what is the effect of harvesting testicular tissue in childhood on their later pubertal development and fertility?
Goossens, E., Van Der Werff Ten Bosch, J., Gies, I. & Tournaye, H.
1/01/18 → 31/12/19
Project: Fundamental
IWTTBM13: Development of a functional and a molecular assay for diagnosis of TLR / NF-KB associated immunodeficiencies.
Van Der Werff Ten Bosch, J. & Allard, S.
1/11/14 → 31/12/17
Project: Fundamental

1263 Citations
13 h-Index
71 Article
13 Meeting abstract (Journal)
3 Poster
2 Scientific review
More
- 1 Meeting abstract (Book)
- 1 Comment/debate

Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience
International Society of Pediatric Oncology Renal Tumor Study Group (SIOP-RTSG) & Van Der Werff Ten Bosch, J., 15 Feb 2021, In : Cancer. 127, 4, p. 628-638 11 p.
Research output: Contribution to journal › Article
Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency
Naesens, L., Smet, J., Tavernier, S. J., Schelstraete, P., Hoste, L., Lambrecht, S., Verhelst, H., van der Werff Ten Bosch, J., Ferster, A., Blumental, S., Hilbert, P., Kerre, T., Van de Walle, J., Licht, C., Roumenina, L. T., Stordeur, P. & Haerynck, F., Feb 2021, In : Journal of Allergy and Clinical Immunology. 147, 2, p. 749-753.e2 5 p.
Research output: Contribution to journal › Article
Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
Depreter, B., De Moerloose, B., Vandepoele, K., Uyttebroeck, A., Van Damme, A., Denys, B., Dedeken, L., Dresse, M-F., Van der Werff Ten Bosch, J., Hofmans, M., Kerre, T., Vandekerckhove, B., Philippé, J. & Lammens, T., Apr 2020, In : HemaSphere. 4, 2, p. e346-e346 1 p.
Research output: Contribution to journal › Article
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach
Depreter, B., De Moerloose, B., Vandepoele, K., Uyttebroeck, A., Van Damme, A., Terras, E., Denys, B., Dedeken, L., Dresse, M-F., Van der Werff Ten Bosch, J., Hofmans, M., Philippé, J. & Lammens, T., 2020, In : Pediatric Research.
Research output: Contribution to journal › Article
DNAJC21 mutations as a cause of early onset bone marrow failure: report of two cases
Damen, E. D., Van Den Akker, M., Diallo, S., Uyttebroeck, S., Hauser, B. & Van Der Werff Ten Bosch, J., 2020, In : Belg. J. Hematol.. 11, 6, p. 269-272 4 p.
Research output: Contribution to journal › Article

21 Participation in conference
6 Talk or presentation at a conference
2 Participation in workshop, seminar
2 Talk or presentation at a workshop/seminar

PID and malignancy
Jutte Van Der Werff Ten Bosch (Speaker)
27 Jan 2020
Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Evaluation of the 58081 study: did we reach our goals?
Jutte Van Der Werff Ten Bosch (Speaker)
30 Jan 2020
Activity: Talk or presentation › Talk or presentation at a workshop/seminar
IPIC 2019
Jutte Van Der Werff Ten Bosch (Participant)
6 Nov 2019 → 7 Nov 2019
Activity: Participating in or organising an event › Participation in conference
Annual COST meeting
Jutte Van Der Werff Ten Bosch (Organiser)
24 Nov 2019 → 26 Nov 2019
Activity: Participating in or organising an event › Participation in conference
PID and malignancy
Jutte Van Der Werff Ten Bosch (Speaker)
19 May 2019 → 21 May 2019
Activity: Talk or presentation › Talk or presentation at a conference

Health-related quality of life, psychological outcome and neurocognitive function in metastatic melanoma survivors treated with immune checkpoint inhibitors
Author: Rogiers, A. I., De Ridder, M., Neyns, B., Everaert, H., Van Der Werff Ten Bosch, J., Distelmans, W., Engelborghs, S., Verdonck, I., Razavi, D. & Kornreich, C., 8 Jul 2020
Supervisor: De Ridder, M. (Promotor), Neyns, B. (Co-promotor), Everaert, H. (Jury), Van Der Werff Ten Bosch, J. (Jury), Distelmans, W. (Jury), Engelborghs, S. (Jury), Verdonck, I. (External person) (Jury), Razavi, D. (External person) (Jury) & Kornreich, C. (Jury)
Student thesis: Doctoral Thesis
Lange termijn effecten van de behandeling met vincristine op fysieke en mentale parameters bij overlevers van kinderkanker : een pilootstudie
Author: Foederer, J., Adriaenssens, N., Van Der Werff Ten Bosch, J. & Van Ginderdeuren, F., 2016
Student thesis: Master's Thesis